Results
54
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
54 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$360.97 | 3.1% | 13.4% | US$11.0b | US$343.83 | PE30.6x | E11.2% | n/a | ||
A001060 | ₩23,900.00 | -1.0% | -29.3% | ₩597.5b | ₩39,500.00 | PE8.4x | E14.4% | 1.9% | ||
4519 | JP¥6,755.00 | 6.1% | 24.6% | JP¥11.1t | JP¥7,510.00 | PE28.7x | E5.3% | 1.5% | ||
600285 | CN¥21.45 | -1.0% | 12.5% | CN¥12.1b | CN¥30.05 | PE17.9x | E16.2% | 3.7% | ||
CTE | AU$0.74 | 0% | 14.6% | AU$36.4m | n/a | PE19.8x | n/a | 2.7% | ||
540737 | ₹785.60 | 6.0% | 13.6% | ₹10.1b | n/a | PE35.5x | n/a | 0% | ||
MPCI | ج.م60.03 | 3.7% | -43.2% | ج.م1.4b | n/a | PE4.4x | n/a | 6.7% | ||
CPRX | US$23.06 | -0.6% | 72.5% | US$2.8b | US$32.22 | PE19.3x | E16.7% | n/a | ||
SATKARTAR | ₹216.55 | 42.2% | n/a | ₹3.4b | n/a | PE54.1x | n/a | n/a | ||
4015 | ر.س163.00 | -0.2% | 15.6% | ر.س11.4b | ر.س176.90 | PE32.7x | E10.9% | 2.0% | ||
HVO | UK£0.18 | -2.6% | -38.0% | UK£125.9m | UK£0.33 | PE7.2x | E-32.9% | 1.1% | ||
A185750 | ₩84,000.00 | -1.8% | -20.4% | ₩1.1t | ₩126,000.00 | PE5.9x | E-25.3% | 1.2% | ||
7079 | JP¥3,365.00 | -1.0% | -27.1% | JP¥8.1b | n/a | PE8.5x | n/a | 2.2% | ||
4587 | JP¥2,014.00 | -6.2% | 56.5% | JP¥261.0b | JP¥3,442.86 | PE15.3x | E4.3% | n/a | ||
300573 | CN¥71.20 | 2.0% | -37.5% | CN¥12.5b | n/a | PE35.8x | n/a | 2.9% | ||
688578 | CN¥71.80 | 5.1% | 72.3% | CN¥32.3b | CN¥75.00 | PE24.9x | E18.9% | 0.7% | ||
500420 | ₹3,161.35 | -5.8% | 19.4% | ₹1.1t | ₹3,639.83 | PE57.5x | E23.3% | 0.9% | ||
NATCOPHARM | ₹1,328.00 | 14.3% | 55.0% | ₹237.9b | ₹1,349.17 | PE12.2x | E-19.1% | 0.4% | ||
JAGSNPHARM | ₹273.48 | 9.9% | 132.4% | ₹18.1b | n/a | PE34.7x | n/a | 0.7% | ||
300896 | CN¥172.96 | 1.7% | -23.9% | CN¥52.1b | CN¥266.90 | PE25.7x | E16.3% | 0% | ||
CPCI | ج.م100.47 | -0.5% | 45.9% | ج.م1.5b | n/a | PE5.7x | n/a | 12.8% | ||
HALO | US$57.94 | 2.7% | 64.4% | US$7.3b | US$64.75 | PE18.8x | E17.3% | n/a | ||
A096760 | ₩3,075.00 | 0.5% | -9.6% | ₩217.5b | n/a | PE3.2x | n/a | 3.7% | ||
1681 | HK$8.30 | 5.5% | 58.4% | HK$6.9b | HK$10.20 | PE7.7x | E14.7% | 7.0% |